Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up.

由 de Mascarel, I., Bonichon, F., Coindre, J. M., Trojani, M.
出版 1992

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.

由 Trojani, M., de Mascarel, I., Coindre, J. M., Bonichon, F.
出版 1987

Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.

由 Trojani, M., de Mascarel, I., Bonichon, F., Coindre, J. M., Delsol, G.
出版 1987

An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue.

由 Terrier, P., Townsend, A. J., Coindre, J. M., Triche, T. J., Cowan, K. H.
出版 1990

Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

由 Soubeyran, I., Quénel, N., Mauriac, L., Durand, M., Bonichon, F., Coindre J-M
出版 1996

Expression of MDR1/P glycoprotein in human sarcomas.

由 Vergier, B., Cany, L., Bonnet, F., Robert, J., de Mascarel, A., Coindre, J. M.
出版 1993

Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

由 Rudolph, P., Kellner, U., Chassevent, A., Collin, F., Bonichon, F., Parwaresch, R., Coindre, J. M.
出版 1997

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

由 Soubeyran, I., Quénel, N., Coindre, J. M., Bonichon, F., Durand, M., Wafflart, J., Mauriac, L.
出版 1996

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

由 MacGrogan, G., Mauriac, L., Durand, M., Bonichon, F., Trojani, M., de Mascarel, I., Coindre, J. M.
出版 1996

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.

由 Ravaud, A., Bui, N. B., Coindre, J. M., Lagarde, P., Tramond, P., Bonichon, F., Stöckle, E., Kantor, G., Trojani, M., Chauvergne, J.
出版 1992

Clear Cell Sarcoma (Malignant Melanoma) of Soft Parts: A Clinicopathologic Study of 52 Cases

由 Hocar, O., Le Cesne, A., Berissi, S., Terrier, P., Bonvalot, S., Vanel, D., Auperin, A., Le Pechoux, C., Bui, B., Coindre, J. M., Robert, C.
出版 2012

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

由 Italiano, A., Le Cesne, A., Bellera, C., Piperno-Neumann, S., Duffaud, F., Penel, N., Cassier, P., Domont, J., Takebe, N., Kind, M., Coindre, J.-M., Blay, J.-Y., Bui, B.
出版 2013

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer

由 MacGrogan, G, Rudolph, P, Mascarel, I de, Mauriac, L, Durand, M, Avril, A, Dilhuydy, J M, Robert, J, Mathoulin-Pélissier, S, Picot, V, Floquet, A, Sierankowski, G, Coindre, J M
出版 2003

Prognosis and predictive value of KIT exon 11 deletion in GISTs

由 Bachet, J-B, Hostein, I, Le Cesne, A, Brahimi, S, Beauchet, A, Tabone-Eglinger, S, Subra, F, Bui, B, Duffaud, F, Terrier, P, Coindre, J-M, Blay, J-Y, Emile, J-F
出版 2009

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)

由 Bugat, R, Bataillard, A, Lesimple, T, Voigt, J J, Culine, S, Lortholary, A, Merrouche, Y, Ganem, G, Kaminsky, M C, Negrier, S, Perol, M, Laforêt, C, Bedossa, P, Bertrand, G, Coindre, J M, Fizazi, K
出版 2003

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas

由 Brahmi, M., Lesluyes, T., Dufresne, A., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Valentin, T., Chevreau, C., Bonvalot, S., Penel, N., Coindre, J.-M., Le Guellec, S., Le Loarer, F., Karanian, M., Blay, J.-Y., Chibon, F.
發表在 ESMO Open (2021)

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

由 Dômont, J, Salas, S, Lacroix, L, Brouste, V, Saulnier, P, Terrier, P, Ranchère, D, Neuville, A, Leroux, A, Guillou, L, Sciot, R, Collin, F, Dufresne, A, Blay, J-Y, Le Cesne, A, Coindre, J-M, Bonvalot, S, Bénard, J
出版 2010

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

由 Ray-Coquard, I., Montesco, M. C., Coindre, J. M., Dei Tos, A. P., Lurkin, A., Ranchère-Vince, D., Vecchiato, A., Decouvelaere, A. V., Mathoulin-Pélissier, S., Albert, S., Cousin, P., Cellier, D., Toffolatti, L., Rossi, C. R., Blay, J. Y.
出版 2012

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

由 Dufresne, A., Lesluyes, T., Ménétrier-Caux, C., Brahmi, M., Darbo, E., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Le Guellec, S., Valentin, T., Chevreau, C., Bonvalot, S., Robin, Y.M., Coindre, J-M, Caux, C., Blay, J.Y., Chibon, F.
發表在 Oncoimmunology (2020)

Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study(†)

由 Mathoulin-Pélissier, S., Chevreau, C., Bellera, C., Bauvin, E., Savès, M., Grosclaude, P., Albert, S., Goddard, J., Le Guellec, S., Delannes, M., Bui, B. N., Mendiboure, J., Stoeckle, E., Coindre, J. M., Kantor, G., Kind, M., Cowppli-Bony, A., Hoppe, S., Italiano, A.
出版 2014